Delivery Order SPE2DB22D1017-SPE2DB25FG7TA

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. federal government. The contract is for the provision of the prescription medication XCOPRI 100 MG TABLET 30S, with a ceiling value of $1,154.12 and a period of performance ending on April 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,709.34 firm fixed price contract is for the supply of 30-count tablets of the pharmaceutical product XCOPRI 100 MG. The ultimate completion date is September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the DLA to...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply the government with XCOPRI 50 MG TABLET 30S. The contract has a firm fixed price and a ceiling value of $1,989.69. It is not a set-aside contract, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $1,836.63 and a period of performance through July 2, 2025. There is no set-aside designation, indicating this was an open competition. Amerisourcebergen Drug Corp holds a...

This is a $6,791.27 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication XCOPRI 100 MG TABLET 30S. The award has an ultimate completion date of August 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, with a ceiling value of $1,514.24 and a period of performance through May 13, 2025. The contract is not set aside for any particular business size or type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,818.73 firm fixed price order is for the supply of 50 mg tablets of the anti-seizure medication Xcopri, with a performance period through March 18, 2024. The order is placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.20, is for the delivery of 4567957363 ! XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 18, 2025. This contract is not a set-aside and is an open competition award. AmerisourceBergen Drug...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,357.92, is for the supply of XCOPRI 200 MG TABLET 30S, a medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 10, 2025. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,641.66 firm fixed price delivery order is for the supply of XCOPRI 50 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of August 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...